The Evaluation of Tau Deposition with [18F]PI-2620 by Using a Semiquantitative Method in Cognitively Normal Subjects and Patients with Mild Cognitive Impairment and Alzheimer’s Disease
Background. Some studies have reported the effectiveness of [18F]PI-2620 as an effective tau-binding radiotracer; however, few reports have applied semiquantitative analysis to the tracer. Therefore, this study’s aim was to perform a semiquantitative analysis of [18F]PI-2620 in individuals with norm...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2021-01-01
|
| Series: | Molecular Imaging |
| Online Access: | http://dx.doi.org/10.1155/2021/6640054 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832544724975616000 |
|---|---|
| author | Attapon Jantarato Sira Vachatimanont Natphimol Boonkawin Sukanya Yaset Anchisa Kunawudhi Chetsadaporn Promteangtrong Jintana Assanasen Nithi Mahanonda Chanisa Chotipanich |
| author_facet | Attapon Jantarato Sira Vachatimanont Natphimol Boonkawin Sukanya Yaset Anchisa Kunawudhi Chetsadaporn Promteangtrong Jintana Assanasen Nithi Mahanonda Chanisa Chotipanich |
| author_sort | Attapon Jantarato |
| collection | DOAJ |
| description | Background. Some studies have reported the effectiveness of [18F]PI-2620 as an effective tau-binding radiotracer; however, few reports have applied semiquantitative analysis to the tracer. Therefore, this study’s aim was to perform a semiquantitative analysis of [18F]PI-2620 in individuals with normal cognition and patients with mild cognitive impairment (MCI) and Alzheimer’s disease (AD). Methods. Twenty-six cognitively normal (CN) subjects, 7 patients with AD, and 36 patients with MCI were enrolled. A dynamic positron emission tomography (PET) scan was performed 30–75 min postinjection. PET and T1-weighted magnetic resonance imaging scans were coregistered. The standardized uptake value ratio (SUVr) was used for semiquantitative analysis. The P-Mod software was applied to create volumes of interest. The ANOVA and post hoc Tukey HSD were used for statistical analysis. Results. In the AD group, the occipital lobe had a significantly higher mean SUVr (1.46±0.57) than in the CN and MCI groups. Compared with the CN group, the AD group showed significantly higher mean SUVr in the fusiform gyrus (1.06±0.09 vs. 1.49±0.86), inferior temporal (1.07±0.07 vs. 1.46±0.08), parietal lobe, lingual gyrus, and precuneus regions. Similarly, the AD group demonstrated a higher mean SUVr than the MCI group in the precuneus, lingual, inferior temporal, fusiform, supramarginal, orbitofrontal, and superior temporal regions. The remaining observed regions, including the striatum, basal ganglia, thalamus, and white matter, showed a low SUVr across all groups with no statistically significant differences. Conclusion. A significantly higher mean SUVr of [18F]PI-2620 was observed in the AD group; a significant area of the brain in the AD group demonstrated tau protein deposit in concordance with Braak Stages III–V, providing useful information to differentiate AD from CN and MCI. Moreover, the low SUVr in the deep striatum and thalamus could be useful for excluding primary tauopathies. |
| format | Article |
| id | doaj-art-f5015eb0ebb846bb8f00d514ba4b9c1e |
| institution | Kabale University |
| issn | 1536-0121 |
| language | English |
| publishDate | 2021-01-01 |
| publisher | SAGE Publishing |
| record_format | Article |
| series | Molecular Imaging |
| spelling | doaj-art-f5015eb0ebb846bb8f00d514ba4b9c1e2025-02-03T10:07:23ZengSAGE PublishingMolecular Imaging1536-01212021-01-01202110.1155/2021/66400546640054The Evaluation of Tau Deposition with [18F]PI-2620 by Using a Semiquantitative Method in Cognitively Normal Subjects and Patients with Mild Cognitive Impairment and Alzheimer’s DiseaseAttapon Jantarato0Sira Vachatimanont1Natphimol Boonkawin2Sukanya Yaset3Anchisa Kunawudhi4Chetsadaporn Promteangtrong5Jintana Assanasen6Nithi Mahanonda7Chanisa Chotipanich8National Cyclotron and PET Centre, Chulabhorn Hospital, Chulabhorn Royal Academy, ThailandNational Cyclotron and PET Centre, Chulabhorn Hospital, Chulabhorn Royal Academy, ThailandNational Cyclotron and PET Centre, Chulabhorn Hospital, Chulabhorn Royal Academy, ThailandNational Cyclotron and PET Centre, Chulabhorn Hospital, Chulabhorn Royal Academy, ThailandNational Cyclotron and PET Centre, Chulabhorn Hospital, Chulabhorn Royal Academy, ThailandNational Cyclotron and PET Centre, Chulabhorn Hospital, Chulabhorn Royal Academy, ThailandNational Cyclotron and PET Centre, Chulabhorn Hospital, Chulabhorn Royal Academy, ThailandChulabhorn Hospital, Chulabhorn Royal Academy, ThailandNational Cyclotron and PET Centre, Chulabhorn Hospital, Chulabhorn Royal Academy, ThailandBackground. Some studies have reported the effectiveness of [18F]PI-2620 as an effective tau-binding radiotracer; however, few reports have applied semiquantitative analysis to the tracer. Therefore, this study’s aim was to perform a semiquantitative analysis of [18F]PI-2620 in individuals with normal cognition and patients with mild cognitive impairment (MCI) and Alzheimer’s disease (AD). Methods. Twenty-six cognitively normal (CN) subjects, 7 patients with AD, and 36 patients with MCI were enrolled. A dynamic positron emission tomography (PET) scan was performed 30–75 min postinjection. PET and T1-weighted magnetic resonance imaging scans were coregistered. The standardized uptake value ratio (SUVr) was used for semiquantitative analysis. The P-Mod software was applied to create volumes of interest. The ANOVA and post hoc Tukey HSD were used for statistical analysis. Results. In the AD group, the occipital lobe had a significantly higher mean SUVr (1.46±0.57) than in the CN and MCI groups. Compared with the CN group, the AD group showed significantly higher mean SUVr in the fusiform gyrus (1.06±0.09 vs. 1.49±0.86), inferior temporal (1.07±0.07 vs. 1.46±0.08), parietal lobe, lingual gyrus, and precuneus regions. Similarly, the AD group demonstrated a higher mean SUVr than the MCI group in the precuneus, lingual, inferior temporal, fusiform, supramarginal, orbitofrontal, and superior temporal regions. The remaining observed regions, including the striatum, basal ganglia, thalamus, and white matter, showed a low SUVr across all groups with no statistically significant differences. Conclusion. A significantly higher mean SUVr of [18F]PI-2620 was observed in the AD group; a significant area of the brain in the AD group demonstrated tau protein deposit in concordance with Braak Stages III–V, providing useful information to differentiate AD from CN and MCI. Moreover, the low SUVr in the deep striatum and thalamus could be useful for excluding primary tauopathies.http://dx.doi.org/10.1155/2021/6640054 |
| spellingShingle | Attapon Jantarato Sira Vachatimanont Natphimol Boonkawin Sukanya Yaset Anchisa Kunawudhi Chetsadaporn Promteangtrong Jintana Assanasen Nithi Mahanonda Chanisa Chotipanich The Evaluation of Tau Deposition with [18F]PI-2620 by Using a Semiquantitative Method in Cognitively Normal Subjects and Patients with Mild Cognitive Impairment and Alzheimer’s Disease Molecular Imaging |
| title | The Evaluation of Tau Deposition with [18F]PI-2620 by Using a Semiquantitative Method in Cognitively Normal Subjects and Patients with Mild Cognitive Impairment and Alzheimer’s Disease |
| title_full | The Evaluation of Tau Deposition with [18F]PI-2620 by Using a Semiquantitative Method in Cognitively Normal Subjects and Patients with Mild Cognitive Impairment and Alzheimer’s Disease |
| title_fullStr | The Evaluation of Tau Deposition with [18F]PI-2620 by Using a Semiquantitative Method in Cognitively Normal Subjects and Patients with Mild Cognitive Impairment and Alzheimer’s Disease |
| title_full_unstemmed | The Evaluation of Tau Deposition with [18F]PI-2620 by Using a Semiquantitative Method in Cognitively Normal Subjects and Patients with Mild Cognitive Impairment and Alzheimer’s Disease |
| title_short | The Evaluation of Tau Deposition with [18F]PI-2620 by Using a Semiquantitative Method in Cognitively Normal Subjects and Patients with Mild Cognitive Impairment and Alzheimer’s Disease |
| title_sort | evaluation of tau deposition with 18f pi 2620 by using a semiquantitative method in cognitively normal subjects and patients with mild cognitive impairment and alzheimer s disease |
| url | http://dx.doi.org/10.1155/2021/6640054 |
| work_keys_str_mv | AT attaponjantarato theevaluationoftaudepositionwith18fpi2620byusingasemiquantitativemethodincognitivelynormalsubjectsandpatientswithmildcognitiveimpairmentandalzheimersdisease AT siravachatimanont theevaluationoftaudepositionwith18fpi2620byusingasemiquantitativemethodincognitivelynormalsubjectsandpatientswithmildcognitiveimpairmentandalzheimersdisease AT natphimolboonkawin theevaluationoftaudepositionwith18fpi2620byusingasemiquantitativemethodincognitivelynormalsubjectsandpatientswithmildcognitiveimpairmentandalzheimersdisease AT sukanyayaset theevaluationoftaudepositionwith18fpi2620byusingasemiquantitativemethodincognitivelynormalsubjectsandpatientswithmildcognitiveimpairmentandalzheimersdisease AT anchisakunawudhi theevaluationoftaudepositionwith18fpi2620byusingasemiquantitativemethodincognitivelynormalsubjectsandpatientswithmildcognitiveimpairmentandalzheimersdisease AT chetsadapornpromteangtrong theevaluationoftaudepositionwith18fpi2620byusingasemiquantitativemethodincognitivelynormalsubjectsandpatientswithmildcognitiveimpairmentandalzheimersdisease AT jintanaassanasen theevaluationoftaudepositionwith18fpi2620byusingasemiquantitativemethodincognitivelynormalsubjectsandpatientswithmildcognitiveimpairmentandalzheimersdisease AT nithimahanonda theevaluationoftaudepositionwith18fpi2620byusingasemiquantitativemethodincognitivelynormalsubjectsandpatientswithmildcognitiveimpairmentandalzheimersdisease AT chanisachotipanich theevaluationoftaudepositionwith18fpi2620byusingasemiquantitativemethodincognitivelynormalsubjectsandpatientswithmildcognitiveimpairmentandalzheimersdisease AT attaponjantarato evaluationoftaudepositionwith18fpi2620byusingasemiquantitativemethodincognitivelynormalsubjectsandpatientswithmildcognitiveimpairmentandalzheimersdisease AT siravachatimanont evaluationoftaudepositionwith18fpi2620byusingasemiquantitativemethodincognitivelynormalsubjectsandpatientswithmildcognitiveimpairmentandalzheimersdisease AT natphimolboonkawin evaluationoftaudepositionwith18fpi2620byusingasemiquantitativemethodincognitivelynormalsubjectsandpatientswithmildcognitiveimpairmentandalzheimersdisease AT sukanyayaset evaluationoftaudepositionwith18fpi2620byusingasemiquantitativemethodincognitivelynormalsubjectsandpatientswithmildcognitiveimpairmentandalzheimersdisease AT anchisakunawudhi evaluationoftaudepositionwith18fpi2620byusingasemiquantitativemethodincognitivelynormalsubjectsandpatientswithmildcognitiveimpairmentandalzheimersdisease AT chetsadapornpromteangtrong evaluationoftaudepositionwith18fpi2620byusingasemiquantitativemethodincognitivelynormalsubjectsandpatientswithmildcognitiveimpairmentandalzheimersdisease AT jintanaassanasen evaluationoftaudepositionwith18fpi2620byusingasemiquantitativemethodincognitivelynormalsubjectsandpatientswithmildcognitiveimpairmentandalzheimersdisease AT nithimahanonda evaluationoftaudepositionwith18fpi2620byusingasemiquantitativemethodincognitivelynormalsubjectsandpatientswithmildcognitiveimpairmentandalzheimersdisease AT chanisachotipanich evaluationoftaudepositionwith18fpi2620byusingasemiquantitativemethodincognitivelynormalsubjectsandpatientswithmildcognitiveimpairmentandalzheimersdisease |